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Medicinal plants are considered to be an important source of antioxidant compo-
unds and the therapeutic benefit of many medicinal plants is often attributed to their an-
tioxidant properties (1, 2). Teucrium polium (Lamiaceae) is a wild-growing flowering plant,
found abundantly in South-Western Asia, Europe and North Africa. T. polium is well known
for its diuretic, antipyretic, diaphoretic, antispasmodic, tonic, anti-inflammatory, antihy-
pertensive, anorexic, analgesic (3, 4), antibacterial (5) and antidiabetic effects (6). Recently,
it has been reported that the extract of T. polium reduces NADPH-initiated lipid pero-
xidation in rat liver microsomes in vitro (7). Plants belonging to the genus Teucrium have
been shown to contain different classes of compounds such as fatty acid esters (8), di-
terpenes (9), monoterpenes (10), sesquiterpenes (11), flavonoids and polyphenolics (12,
13). Flavonoids that have been isolated from T. polium species include cirsimaritin, cir-
silol, cirsilineol, 5-hydroxy-6,7,3’,4’-tetramethoxyflavone, salvigenin, apigenin 5-galloyl-
glucoside, apigenin-7-glucoside, vicenin-2- and luteolin-7-glucoside (6, 12, 14). The anti-
oxidant potential of cirsimaritin and apigenin-7-glucoside has been indicated (15). Vicenin
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The present study was undertaken to explore antioxidant
potential of Teucrium polium (Lamiaceae) in vivo. Antioxi-
dant activity was measured by three tests including inhi-
bition of 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical,
total antioxidant power (TAP), and thiobarbituric acid re-
active substances (TBARS) in serum. Rats received dry ex-
tract of T. polium in 80% ethanol by intragastric intuba-
tion at doses of 50, 100 and 200 mg kg–1 daily for 14 days.
Treatment of rats with T. polium extract showed signifi-
cant antioxidant activity in the DPPH test as compared
to the control. T. polium extract at doses of 50 and 100 mg
kg–1 significantly increased rats TAP and decreased TBARS
compared to the control. Administration of T. polium at a
dose of 200 mg kg–1 per day did not significantly alter
serum TAP and TBARS. Antioxidant activities of T. poli-
um at a doses of 50 and 100 mg kg–1 were in all experi-
ments comparable to that of a-tocopherol (10 mg kg–1).
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and luteolin-7-glucoside have shown the strongest antioxidant activity in in vitro tests
(16). Polyphenolic compounds have also shown strong antioxidant activity (14). The po-
sitive effects of these antioxidant components come from their ability to inhibit lipid pe-
roxidation and chelate redox-active metals (17). There is evidence that flavonoids have
anti-phosphodiesterase activity and could thus elevate intracellular levels of cyclic nu-
cleotides (18). Recent studies indicate that both cyclic adenosine monophosphate (cAMP)
and cyclic guanosine monophosphate (cGMP) can diminish oxidative stress in many bio-
logical systems and diseases in vivo (19, 20).
Because of the effect of free radicals on all cellular macromolecules, which result in var-
ious diseases, it seemed interesting to study the antioxidant potential of T. polium in vivo.
EXPERIMENTAL
Plant material and total extract
Aerial parts of T. polium were collected during the flowering period in the region of
Kerman borders (East Iran). Samples of the plant were identified by a botanist from the
Division of Pharmacognosy, Tehran University of Medical Sciences (TUMS), Iran.
The plant material was air dried, powdered and extracted by the percolation me-
thod using ethanol (80%). The solvent was removed under vacuum in a rotary evapora-
tor until dryness (14%, m/m, of dry plant).
Chemicals
All chemicals were of highest purity (³ 99.0%). Sodium acetate, 2,4,6-tripyridyl-s-
triazine (TPTZ), 2-thiobarbituric acid (TBA), 1,1,3,3-tetramethoxypropan (MDA), trichlo-
roacetic acid (TCA), glacial acetic acid, 1,1-diphenyl-2-picryl hydrazyl (DPPH), FeCl3 ´
6 H2O, HCl, and n-butyl alcohol were purchased from Merck Iran. a-Tocopherol (Trolox)
was purchased from ACROS organics, Belgium.
Animals and treatment
Experiments were performed on adult male Wistar rats from the Pasteur Institute of
Tehran (Iran) weighing 180–200 g. They were kept under standardized conditions (tem-
perature 21–24 °C and a light/dark cycle of 12 hours/12 hours) and fed a normal labora-
tory diet. After 1 week of acclimatization, rats were divided into one control and four
experimental groups with 6 animals in each group. The study protocol was approved by
the Pharmaceutical Sciences Research Center (PSRC)/TUMS Ethics Committee.
The extract was dissolved in normal saline to provide a 20 mg mL–1 solution. Ani-
mals from group 1 to 3 received doses expressed on the basis of mg dry extract per kg
body mass, namely 50, 100, and 200 mg kg–1 per day of the extract by intragastric intu-
bation for 14 days. Group 4 received a-tocopherol (10 mg kg–1 per day) dissolved in sa-
line by intragastric intubation as a reference antioxidant for comparison. The fifth group
of animals was treated as control and received only saline.
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Blood collection
About 4 mL of blood was collected through direct heart puncture from anesthetized
rats. Intraperitoneal administration of pentobarbital (60 mg kg–1) was used to induce ane-
sthesia in rats. The blood was centrifuged at 2000 × g for 10 minutes to separate serum.
The serum was kept at –20 °C for subsequent determination of lipid peroxidation and
antioxidant status.
Lipid peroxidation assay
Thiobarbituric Acid Reactive Substances (TBARS) assay is the method of choice for
screening and monitoring lipid peroxidation, a major indicator of oxidative stress. To pre-
cipitate the serum proteins, 2.5 mL of TCA 20% (m/V) was added into 0.5 mL of the sam-
ple, which was then centrifuged at 1500 × g for 10 min. Then 2.5 mL of sulfuric acid (0.05
m L–1) and 2 mL TBA (0.2%) was added to the sediment, shaken, and incubated for 30
min in a boiling water bath. Then, 4 mL n-butanol was added, and the solution was cen-
trifuged, cooled and the supernatant absorption was recorded at 532 nm using a UV-Visible
spectrophotometer (Shimadzu, Japan). The calibration curve was obtained using different
concentrations of 1,1,3,3-tetramethoxypropane as standard to determine the concentra-
tion of TBA-MDA adducts in samples (21).
Total antioxidant power (TAP) assay
The total antioxidant capacity of serum was determined by measuring its ability to
reduce Fe3+ to Fe2+ by the FRAP (Ferric Reducing Ability of Plasma) test. The FRAP as-
say measures the change in absorbance at 593 nm owing to the formation of a blue color-
ed Fe(II)-tripyridyltriazine compound from Fe(III) by the action of electron donating an-
tioxidants. The FRAP reagent consists of 300 mmol L–1 acetate buffer pH = 3.6, 10 mmol
L–1 TPTZ in 40 mmol L–1 HCl and 20 mmol L–1 FeCl3 ´ 6 H2O in the ratio of 10:1:1.
Briefly, 10 mL of serum was added to 300 mL freshly prepared and prewarmed (37 °C)
FRAP reagent in a test tube and incubated at 37 °C for 10 min. The absorbance of the
blue colored complex was read against a reagent blank (300 mL FRAP reagent + 10 mL
distilled water) at 593 nm. Standard solutions of Fe2+ in the range of 100 to 1000 mmol
L–1 were prepared from ferrous sulphate (FeSO4 ´ 7 H2O) in water. The data was ex-
pressed as mmol ferric ions reduced to ferrous form per liter (FRAP value) (22).
DPPH radical scavenging activity
In this test, serum ability to inhibit DPPH radical was measured (23). DPPH is one
of the few stable organic nitrogen radicals and has a maximum of absorption at 517 nm.
20 mL of rat’s serum was added to 3 mL of DPPH solution (0.1 mmol L–1 in ethanol) and
the reaction mixture was shaken vigorously. After incubation at room temperature for 10
min, the absorbance of this solution was determined at 517 nm DPPH solutions without
serum and with a-tocopherol were used as the control and reference, respectively.
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Determination of LD50
In order to determine the acute toxicity (LD50) of T. polium, doses of 10, 100, 1000, and
2000 mg kg–1 of the day extract were administrated to rats via intragastric tube. The ani-
mals were observed for 48 h and mortality was recorded at the end of this period (24).
Statistical analysis
The values are reported as mean ± SEM. One-way ANOVA and Tukey posthoc mul-
ticomparison tests were used for data analysis.
RESULTS AND DISCUSSION
The acute toxicity test (LD50) demonstrated that T. polium extract is not lethal up to a
dose of 2000 mg kg–1.
T. polium extracts in all doses (mg kg–1) used significantly (p < 0.05) increased the se-
rum DPPH scavenging potential when compared to the control as follows: 50 (786%),
100 (907%), 200 (779%). This value for a-tocopherol (10 mg kg–1) compared to the control
was 667% (p < 0.05) (Fig. 1a). T. polium extract in the same doses (mg kg–1), significantly
(p < 0.005) increased the serum TAP when compared to the control as follows: 50 (23.6%),
100 (37.5%) (Fig. 1b) and decreased the serum TBARS when compared to the control as
follows: 50 (24.7%), 100 (31.8%) (Fig. 1c). This value for a-tocopherol (10 mg kg–1) com-
pared to the control in the TAP assay was 16.8% (p < 0.05) and in the TBARS assay 29.5%
(p < 0.05). T. polium at a dose of 200 mg kg–1 per day did not significantly alter the serum
TAP and TBARS.
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Fig. 1. Antioxidant potential of T. polium in as-
says: a) DPPH, b) TAP and c) TBARS compared
to a-tocopherol in rat blood. Data are mean ±
SEM of 6 animals in each group. *Different from
the respective control (p < 0.05). a-Tocopherol
(a-toco) was administered at a dose of 10 mg
kg–1 per day.
Data obtained by DPPH, FRAP, and TBARS assays indicate that T. polium effectively
inhibits oxidative stress in vivo. When tested by FRAP and TBARS, T. polium extract at a
dose of 200 mg kg–1 per day exhibited no significant antioxidant activity in comparison
to the control. It is proposed that the DPPH test is more sensitive than FRAP and TBARS
tests for examination of the antioxidant capacity of T. polium.
Results of the present in vivo study are supported by the work of Panovska and Ku-
levanova (7) indicating that diethyl ether, ethyl acetate and n-butanol extracts of T. spe-
cies inhibit lipid peroxidation in vitro. In addition, they indicated that the inhibitory ef-
fect of the extracts was greater than that of reference substances such as luteolin, and
similar to that of thymol and butylated hydroxyl toluene. Regarding the presence of fla-
vonoids and polyphenolic compounds such as cirsimaritin, apigenin-7-glucoside, vice-
nin, and luteolin-7-glucoside in the T. polium extract (15, 16), the obtained in vivo results
are not surprising. As mentioned earlier, T. polium has been recognized in folk medicine
in the treatment of diabetes (6). Regarding the role of oxidative stress in the pathoge-
nesis of diabetes (26), the benefit of T. polium in diabetes seems reasonable.
CONCLUSIONS
This preliminary study indicates the interesting antioxidative stress potential of T.
polium in vivo that is comparable to that of a-tocopherol. Further studies are needed to
elucidate whether T. polium could be useful in the management of human diseases re-
sulting from oxidative stress.
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S A @ E T A K
In vivo antioksidativni potencijal biljke Teucrium polium u usporedbi s
a-tokoferolom
PARISA HASANI, NARGUES YASA, SANAZ VOSOUGH-GHANBARI, AZADEH MOHAMMADIRAD,
GHOLAMREZA DEHGHAN i MOHAMMAD ABDOLLAHI
U okviru ovih istra`ivanja ispitan je antioksidativni potencijal biljke Teucrium polium
(Lamiaceae) in vivo. Antioksidativni u~inak mjeren je pomo}u tri testa koji uklju~uju in-
hibiciju 1,1-difenil-2-pikrilhidrazil (DPPH) radikala, ukupnu antioksidativnu snagu (TAP)
i reaktivne supstancije tiobarbiturne kiseline (TBARS) u serumu. [takorima je davan suhi
ekstrakt T. polium u 80%-tnom etanolu intragastri~nom intubacijom u dozama od 50, 100
i 200 mg kg–1 dnevno tijekom 14 dana. Pokusi su pokazali zna~ajno antioksidativno dje-
lovanje T. polium DPPH testom u usporedbi s kontrolom. T. polium je u dozama od 50 i
100 mg kg–1 zna~ajno povisio TAP i snizio TBARS u usporedbi s kontrolom. Primjena
ekstrakta T. polium u dozi od 200 mg kg–1 dnevno nije zna~ajno mijenjala serumske TAP i
TBARS vrijednosti. Antioksidativni u~inak T. polium u dozama 50 i 100 mg kg–1 bio je u
svim eksperimentima sli~an u~incima a-tokoferola (10 mg kg–1).
Preliminarna ispitivanja ukazuju na antistresni u~inak T. polium koji je usporediv anti-
oksidativnom u~inku. Me|utim, potrebna su daljnja ispitivanja da se rasvijetli bi li T.
polium mogla biti korisna u uklanjanju posljedica oksidativnog stresa.
Klju~ne rije~i: Teucrium polium L. (Lamiaceae), antioksidans, DPPH, TAP, TBARS, a-tokoferol
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